Evidence regarding the safety of non-hematopoietic EPO analogues in stroke patients is expected in the near future since one clinical pilot trial of Carbamylated EPO in stroke patients was recently completed and another pilot trial has already started (http://www.clinicaltrials.gov/; NCT00756249 and NCT00870844). Here, EPO is linked to Stroke.